EventsThe 3rd International Online Conference on Biomimetics
Published
This submission belongs to the session S2. Biomimetic Materials—Structures, Surfaces and Interfaces of the event The 3rd International Online Conference on Biomimetics
Published date
19 Nov, 2026
Academic Editor
author-avatarYongmei Zheng
Citation
Ahmad Naim Zarwi, Adnan Abdulkarim Alsaei, Ayah Adel Binrajab, Fatema Nader Rahimi, G. Roshan Deen, Utilizing 3D printed Polycaprolactone scaffolds as a substitute for autografts in orthopedic procedures to facilitate bone regeneration, in Proceedings of The 3rd International Online Conference on Biomimetics, 24 November–26 November 2026, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

Utilizing 3D printed Polycaprolactone scaffolds as a substitute for autografts in orthopedic procedures to facilitate bone regeneration

Adnan Abdulkarim Alsaei 1
Ayah Adel Binrajab 1
Fatema Nader Rahimi 1
image
1. School of Medicine, Royal College of Surgeons in Ireland - Bahrain (RCSI), Busaiteen , Kingdom of Bahrain
Abstract

Background:

Orthopedic procedures have traditionally relied on autografts, where bone is harvested from another site in the patient to repair damage due to trauma, degenerative condition, and other pathologies. While autografts are highly compatible, several limitations exist including limited availability, risk of complications, postoperative pain, and prolonged recovery. To overcome these limitations, researchers have explored synthetic biomaterials that support bone regeration. Polycaprolactone (PCL), a biodegradable polymer, has emerged as a potential candidate to replace autografts in orthopedic applications due to its favorable mechanical properties, biocompatibility, and slow degradation rate.

Aim: The aim of this study is to evaluate the potential of 3D-printed PCL to replace autograft scaffolds in orthopedic applications, specifically investigating parallels in mechanical performance, biocompatibility, and osteogenesis.

Methods:

A series of in-vitro tests and assays will be performed on 3D-printed PCL scaffolds; findings will be compared to autograft data to assess its effectiveness as an alternative to autografts. Statistical analysis will be conducted to determine the significance of differences between the PCL scaffolds and autografts. Mechanical performance will be assessed using compression testing to determine load thresholds, elastic modulus measurements to evaluate scaffold stiffness, and micro-CT scanning to analyze porosity. Biocompatibility will be evaluated by seeing osteoblasts to determine cell adhesion and proliferation, in addition to metabolic assays to detect cytotoxicity. Alkaline phosphatase activity will serve as an indicator of osteogenic potential.

Expected Results:

It is expected that the biomechanical performance and biocompatibility of 3D-printed PCL scaffolds will be comparable to that of autografts. Elevated alkaline phosphatase activity is anticipated, indicating the scaffold’s ability to support osteogenesis in vitro.

Conclusion:

Supportive evidence would suggest that 3D-printed PCL are potential alternatives to autografts in bone regernation in orthopedic applications. Further in vivo studies are required to evaluate durability and biological response.

Keywords
3D Printing
Polycaprolactone (PCL)
Tissue Engineering
Bone Regeneration
Orthopedic
Biomaterials
Osteogenesis
Biocompatibility
Biomimetic Lotus-Leaf Surface Bilayer Hydrogel Dressing for Anti-Biofouling in Diabetic Foot Ulcers: A Conceptual Framework
INTEGRATING AMPHIBIOUS ARCHITECTURE AND BIOMIMETICS AS A SUSTAINABLE DESIGN APPROACH TO FLOOD IMPACT MITIGATION